← Leaderboards
Anna C Sorace
University Of Alabama At Birmingham
$4,325,252
Attributed
$5,861,530
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,861,530 · 6
By mechanism
R01$4,697,312 · 3
S10$600,665 · 1
P30$359,258 · 1
R21$204,295 · 1
Top collaborators
- James M Markert3 shared
- Thomas E Yankeelov3 shared
Most similar at University Of Alabama At Birmingham
Same institution · by research overlap
- James M Markert$5,310,460
- Thomas E Yankeelov$17,847,366
- Kurt R Zinn$3,944,617
- Xiaoguang Margaret Liu$3,757,363
- Runhua Runa Liu$2,517,658
Others in their field
Other Emerging Leaders on “Image”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$321,574,964
- Joel A Lipkin · Four Points Technology, Llc$181,896,915
- Lynn Briscoe · Leidos Biomedical Research, Inc.$119,691,178
- Terry Drinkwine · Carahsoft Technology Corporation$93,011,563
Research focus
ImagePositron-Emission TomographyTumorResponseMagnetic Resonance ImagingCombined Modality TherapyDoseQuantitative ImagingBiologicalImmunotherapyMouse ModelRegimenPre-ClinicalMolecular ImagingPre-Clinical ModelClinically RelevantCancer TherapyImaging ModalityCytotoxic ChemotherapySystemic TherapyMalignant Breast NeoplasmPrediction Of Response To TherapyErbb2 GeneChemotherapy
Grant awards (14)
Utilization of Immuno-PET to detect response and guide novel oHSV-based therapy for glioma$571,444
R01 · FY2025 · CA · contact PI
Mathematical modeling and molecular imaging to maximize response while minimizing toxicities from systemic therapies in preclinical models of breast cancer$466,308
R01 · FY2025 · CA · contact PI
Advanced PET/MRI to quantify heterogeneity of HER2 and vasculature in HER2+ breast-to-brain metastasis prior to combination targeted and radiotherapy$204,295
R21 · FY2025 · CA · contact PI
Utilization of Immuno-PET to detect response and guide novel oHSV-based therapy for glioma$542,873
R01 · FY2024 · CA · contact PI
Mathematical modeling and molecular imaging to maximize response while minimizing toxicities from systemic therapies in preclinical models of breast cancer$442,688
R01 · FY2024 · CA · contact PI
Utilization of Immuno-PET to detect response and guide novel oHSV-based therapy for glioma$571,444
R01 · FY2023 · CA · contact PI
Mathematical modeling and molecular imaging to maximize response while minimizing toxicities from systemic therapies in preclinical models of breast cancer$477,800
R01 · FY2023 · CA · contact PI
Personalizing immunotherapy in HER2+ breast cancer through quantitative imaging$404,986
R01 · FY2023 · CA · contact PI
Personalizing immunotherapy in HER2+ breast cancer through quantitative imaging$413,866
R01 · FY2022 · CA · contact PI
Personalizing immunotherapy in HER2+ breast cancer through quantitative imaging$391,680
R01 · FY2021 · CA · contact PI
Preclinical Imaging Shared Facility$165,067
P30 · FY2021 · CA · contact PI
Major upgrade for UAB Bruker BioSpec preclinical 9.4T MRI$600,665
S10 · FY2020 · OD · contact PI
Personalizing immunotherapy in HER2+ breast cancer through quantitative imaging$414,223
R01 · FY2020 · CA · contact PI
Preclinical Imaging Shared Facility$194,191
P30 · FY2020 · CA · contact PI